<DOC>
	<DOCNO>NCT00180960</DOCNO>
	<brief_summary>The purpose study evaluate treatment cancerous disease peritoneum complete cytoreductive surgery intraperitoneal chemohyperthermia use oxaliplatin plus irinotecan . This Phase II study 100 patient . Origins tumor : include colon , rectum , appendix , peritoneum , endocrine tumor .</brief_summary>
	<brief_title>Treatment Cancerous Disease Peritoneum With Complete Cytoreductive Surgery Intraperitoneal Chemohyperthermia</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Endocrine Gland Neoplasms</mesh_term>
	<mesh_term>Appendiceal Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<criteria>Peritoneal seedings come colon , rectum , pseudomyxoma ( appendix ) , peritoneum ( mesothelioma serous tumor ) , endocrine tumor . No extraabdominal metastasis Good general status ( American Society Anesthesiologists Physical Status score [ ASA ] 1 2 ) Signed consent Tumor seedings come origin Huge peritoneal carcinomatosis ( peritoneal score &gt; 25 , except pseudomyxomas ) Peritoneal carcinomatosis progress rapidly Presence extraabdominal metastasis Patients present contraindication use oxaliplatin irinotecan</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2006</verification_date>
</DOC>